Improving Quality & Equity of Emergency Care Decisions (IQED)

Status Withdrawn

Clinical Trial Summary

Recent work in emergency medicine has shown errors were more likely to occur at the end of shifts, as pressure exists to make a number of decisions simultaneously, and after what may be an already long series of cognitive challenges. Decision fatigue may also contribute to disparities by surfacing subconscious bias. The objective of the R21 pilot phase of Improving Quality & Equity of Emergency Care Decisions (IQED) is to identify addressable gaps in quality and equity and use performance feedback as an intervention to improve performance on chest pain, CT imaging, and antibiotic prescribing. Performance feedback intervention will include feedback offline via email or text.

Clinical Trial Description

The objective of the R21 pilot phase of Improving Quality & Equity of Emergency Care Decisions (IQED) is to identify addressable gaps in quality and equity and use performance feedback as an intervention to improve performance on chest pain, CT imaging, and antibiotic prescribing. Performance feedback intervention will include feedback offline via email or text. Each clinician will be randomized at the provider or clinic level to either the intervention or control group. Once clinicians are randomized, the aforementioned intervention will be turned on for a 3-6 month time period. For providers in the intervention group, the goal is to evaluate the effect of social norms on overuse and underuse behavior related to prescriptions or testing. Near real-time social norms will be delivered to providers which benchmark their own performance on various metrics to that of their peers. The investigators performance feedback reports for each provider randomized to receive the audit and feedback intervention will have three key characteristics: (1) each target provider will receive his or her individual performance, (2) benchmarks will prominently feature the performance of providers who would be considered credible peers of the target provider, and (3) benchmarks will reflect only performance that is desirable (e.g., showing only the performance of the best-performing credible peers). Providers randomized to the control group will follow standard practice. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03966989
Study type	Interventional
Source	University of Southern California
Contact
Status	Withdrawn
Phase	N/A
Start date	December 2021
Completion date	June 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04804306` - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Completed	`NCT04888884` - Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting
Completed	`NCT02903017` - Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage	Phase 4
Active, not recruiting	`NCT04109885` - Paracervical Injection for Headache in the Emergency Department	Phase 2
Active, not recruiting	`NCT06345352` - Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)
Not yet recruiting	`NCT06408142` - Universal Test and Connect for HIV Service Delivery in South Africa
Active, not recruiting	`NCT04008810` - Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
Not yet recruiting	`NCT05545917` - Advanced Practice Physiotherapy Care in Emergency Departments	N/A
Completed	`NCT05093439` - Heart Rate Variability at the Emergency Department
Completed	`NCT06338111` - Interventions Meant to Improve the Outcome of Critical Care Patients in the ED
Completed	`NCT04291417` - Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
Active, not recruiting	`NCT04880733` - Acupuncture in the Emergency Department for Pain Management	N/A
Completed	`NCT04877028` - Frailty Screening in the Swedish Emergency Department Setting
Completed	`NCT04744155` - Reducing Adolescent Pregnancy in the Emergency Department	N/A
Recruiting	`NCT05352399` - Artificial Intelligence + Care Coach Intervention	N/A
Completed	`NCT03082417` - The PAINFREE Initiative, a Stepped Wedge Cluster Randomized Trial	N/A
Completed	`NCT04819035` - Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital
Recruiting	`NCT03051737` - Development and Validation of a Regional Multi-scale System for the Prediction of the Patient Flow in the Emergencies and the Need for Hospitalization
Completed	`NCT03660852` - Impact of a Magnetic Resonance Imaging (MRI) Scanner Exclusively Dedicated to Emergency in the Clinical Management of Patients Presenting With Diplopia or Dizziness
Completed	`NCT05580016` - Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving Quality & Equity of Emergency Care Decisions (IQED) — IQED

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms